These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2895883)

  • 1. Recombinant human granulocyte-macrophage colony-stimulating factor produces fever.
    Peters WP; Shogan J; Shpall EJ; Jones RB; Kim CS
    Lancet; 1988 Apr; 1(8591):950. PubMed ID: 2895883
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical studies of granulocyte-macrophage colony stimulating factor.
    Gutterman J
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):52-3. PubMed ID: 3057645
    [No Abstract]   [Full Text] [Related]  

  • 3. Granulocyte-macrophage colony-stimulating factor and vasculitis.
    Dreicer R; Schiller JH; Carbone PP
    Ann Intern Med; 1989 Jul; 111(1):91-2. PubMed ID: 2660649
    [No Abstract]   [Full Text] [Related]  

  • 4. Nursing care of AIDS patients participating in a Phase I/II trial of recombinant human granulocyte-macrophage colony stimulating factor.
    Lynch M; Yanes L; Todd K
    Oncol Nurs Forum; 1988; 15(4):463-9. PubMed ID: 3041383
    [No Abstract]   [Full Text] [Related]  

  • 5. Necrotizing vasculitis at granulocyte-macrophage-colony-stimulating factor injection sites.
    Farmer KL; Kurzrock R; Gutterman JU; Duvic M
    Arch Dermatol; 1990 Sep; 126(9):1243-4. PubMed ID: 2204310
    [No Abstract]   [Full Text] [Related]  

  • 6. Perforation of an unsuspected cecal granulocytic sarcoma during therapy with granulocyte-macrophage colony-stimulating factor.
    Evans C; Rosenfeld CS; Winkelstein A; Shadduck RK; Pataki KI; Oldham FB
    N Engl J Med; 1990 Feb; 322(5):337-8. PubMed ID: 2404207
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis.
    Champlin RE; Nimer SD; Oette D; Golde DW
    Prog Clin Biol Res; 1990; 338():143-50. PubMed ID: 2189137
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical role of granulocyte-macrophage colony-stimulating factor.
    Mitsuyasu RT; Golde DW
    Hematol Oncol Clin North Am; 1989 Sep; 3(3):411-25. PubMed ID: 2698875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [GM-CSF: its clinical administration; the treatment of aplasia].
    Rossi Ferrini P; Grossi A; Santini V; Vannucchi AM
    Haematologica; 1989 Oct; 74(5 Suppl):489-500. PubMed ID: 2512231
    [No Abstract]   [Full Text] [Related]  

  • 10. GM-CSF treatment and hypokalemia.
    Viens P; Thyss A; Garnier G; Ayela P; Lagrange M; Schneider M
    Ann Intern Med; 1989 Aug; 111(3):263. PubMed ID: 2665594
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy: a phase Ib trial.
    Steis RG; VanderMolen LA; Longo DL; Clark JW; Smith JW; Kopp WC; Ruscetti FW; Creekmore SP; Elwood LJ; Hursey J
    J Natl Cancer Inst; 1990 Apr; 82(8):697-703. PubMed ID: 2138680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man.
    Socinski MA; Cannistra SA; Elias A; Antman KH; Schnipper L; Griffin JD
    Lancet; 1988 May; 1(8596):1194-8. PubMed ID: 2897009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of granulocytopenia in Felty's syndrome by granulocyte-macrophage colony-stimulating factor. Simultaneous induction of interleukin-6 release and flare-up of the arthritis.
    Hazenberg BP; Van Leeuwen MA; Van Rijswijk MH; Stern AC; Vellenga E
    Blood; 1989 Dec; 74(8):2769-70. PubMed ID: 2510837
    [No Abstract]   [Full Text] [Related]  

  • 14. Splenic hematopoiesis following GM-CSF therapy in a patient with hairy cell leukemia.
    Lindemann A; Herrmann F; Mertelsmann R; Gamm H; Rumpelt HJ
    Leukemia; 1990 Aug; 4(8):606-7. PubMed ID: 2201835
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase-I/II trial.
    Ganser A; Völkers B; Greher J; Walther F; Hoelzer D
    Onkologie; 1988 Feb; 11(1):53-5. PubMed ID: 3283627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of recombinant granulocyte-macrophage colony stimulating factor in the Brazil radiation accident.
    Butturini A; De Souza PC; Gale RP; Cordiero JM; Lopes DM; Neto C; Cunha CB; De Souza CE; Ho WG; Tabak DG
    Lancet; 1988 Aug; 2(8609):471-5. PubMed ID: 2900402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of alloimmunization: a potential hazard of GM-CSF treatment in patients with severe aplastic anemia?
    Kuentz M; Bierling P; Norolle F; Cordonnier C; Rochant H; Vernant JP
    Transfusion; 1989 Sep; 29(7):654-5. PubMed ID: 2672436
    [No Abstract]   [Full Text] [Related]  

  • 18. [GM-CSF: its use in onco-hematologic diseases].
    Visani G; Tosi P; Benfenati D; Colombini R; Cenacchi AR; Gamberi B; Lemoli RM; Tura S
    Haematologica; 1989 Oct; 74(5 Suppl):501-10. PubMed ID: 2512232
    [No Abstract]   [Full Text] [Related]  

  • 19. Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor.
    Herrmann F; Schulz G; Lindemann A; Meyenburg W; Oster W; Krumwieh D; Mertelsmann R
    J Clin Oncol; 1989 Feb; 7(2):159-67. PubMed ID: 2644395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical applications of colony-stimulating factors.
    Groopman JE
    Semin Oncol; 1988 Dec; 15(6 Suppl 6):27-33. PubMed ID: 2462748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.